The pathogenesis of atherosclerosis

International Journal of Cardiology

Volumn 62, Issue SUPPL. 2, 1997, Pages S3-

  Schachter, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Atherosclerosis; Growth factors; Smooth muscle cells

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; THROMBOGENESIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0031593126     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0167-5273(97)00235-0     Document Type: Conference Paper

References (32)

1. Ross R., Glomset J.A. Atherosclerosis and the arterial smooth muscle cell. Science. 180:1973;1332-1339.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Gimbrone M.A. Culture of vascular endothelium. Prog Hemost Thromb. 3:1976;1-28.
4. Ross R. Cell biology of atherosclerosis. Ann Rev Physiol. 57:1995;791-804.
5. Oemar B.S., Yang Z., Luscher T.F. Molecular and cellular mechanisms of atherosclerosis. Curr Opin Nephrol Hypertens. 4:1995;82-91.
6. Cohen R.A. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 38:1995;105-128.
7. Parthasarty S., Wieland E., Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low-density lipoprotein. Proc Natl Acad Sci USA. 86:1989;1046-1050.
8. Hansson G.K., Jonasson L., Seifert P.S., Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 9:1989;567-578.
9. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site of macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposits. Proc Natl Acad Sci USA. 76:1979;333-337.
10. Parthasarathy S., Printz D.J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low-density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6:1986;505-510.
11. Schwartz S.M., Heimark R.L., Majesky M.W. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 70:1990;1177-1209.
12. Wight T.N. Cell biology of arterial proteoglycans. Arteriosclerosis. 9:1989;1-20.
13. Thyberg J., Hedin U., Sjöplund M., Palmberg L., Bottger B.A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:1990;966-990.
14. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:1995;487-517.
15. Benditt E.P. Implications of the monoclonal character of human atherosclerotic plaques. Am J Pathol. 86:1977;693-702.
16. Stary H.C., Blankenhorn D.H., Chandler A.B.et al. A definition of the intima of human arteries and its atherosclerosis-prone regions. Arteriosclerosis. 12:1992;120-134.
17. Watanabe T., Shimokama T., Haraoka S., Hishikawa H. T Lymphocytes in atherosclerotic lesions. Ann NY Acad Sci. 748:1995;40-56.
18. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
19. Berliner J.A., Navab M., Fogelman A.M.et al. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation. 91:1995;2488-2496.
20. Cathcart M.K., McNally A.K., Chisholm G.M. Lipoxygenase-mediated transformation of human low-density lipoprotein to an oxidized and cytotoxic complex. J Lipid Res. 32:1991;63-70.
21. Auge N., Pieraggi M.T., Thiers J.C., Negre-Salvayre A., Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 309:1995;1015-1020.
22. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8:1994;1279-1284.
23. Raines E.W., Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 69(1):1993;S30-S37.
24. Gordon D.J., Probstfield J.L., Garrison R.J.et al. High-density lipoprotein cholesterol and cardiovascular disease. Circulation. 79:1989;8-15.
25. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA. 71:1974;1207-1210.
26. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest. 82:1988;1134-1143.
27. Parkes J.L., Cardell R.R., Hubbard F.C., Hubbard D., Meltzer A., Penn A. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol. 138:1991;765-775.
28. Lafont A., Guzman L.A., Whitlow P.L., Goormastic M., Cornhill J.F., Chisolm G.M. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 76:1995;996-1002.
29. Scandinavian Simvastatin Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-1389.
30. Shepherd J., Cobbe S.M., Ford I.et al. Prevention of coronary heart disease in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
31. Hoffman R.M., Garewal H.S. Antioxidants and the prevention of coronary heart disease. Arch Intern Med. 155:1995;241-246.
32. Borcherding S.M., Meeves S.G., Klutman N.E., Howard P.A. Calcium-channel antagonists for the prevention of atherosclerosis. Ann Pharmacother. 27:1993;61-67.